Anaerobic bacteria infectious disease
MONDO:0024389Also known as: anaerobic bacterial infection, infection caused by anaerobic bacteria, infection due to anaerobic bacteria
100 clinical trials for this condition and its sub-types, 2 tagged with Anaerobic bacteria infectious disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Anaerobic bacteria infectious disease
-
Clostridium infectious disease 48 trials · 97 incl. sub-types
3 sub-types
- Tetanus 44 trials Sub-types →
- Botulism 5 trials Sub-types →
- Infection due to clostridium perfringens 0 trials Sub-types →
-
1 sub-type
- Actinomycosis 0 trials Sub-types →
-
Bacteroides infectious disease 0 trials
-
Fusobacterium infectious disease 0 trials
-
Anaerobic balanitis 0 trials
-
Anaerobic cellulitis 0 trials
-
Anaerobic meningitis 0 trials
-
Anaerobic pneumonia 0 trials
-
Infection caused by Bifidobacterium 0 trials
Most studied deeper sub-types
-
New hope for recurring c. diff: which treatment works best?
Disease control Stopped earlyThis study tested three different antibiotic regimens for people with recurrent Clostridium difficile infection (C. diff), a serious gut infection that keeps coming back. The goal was to see if newer drugs like fidaxomicin or a tapered/pulsed course of vancomycin work better than…
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Promising c. diff drug trial halted after just 3 patients
Disease control Stopped earlyThis study tested a new drug called REC-3964 to see if it could prevent repeat Clostridioides difficile (C. diff) infections in adults. Only 3 people were enrolled before the trial was stopped early. The goal was to check safety and whether the drug helped people stay infection-f…
Phase 2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New inhaled drug aimed at stubborn lung infection shows promise, but trial halted early
Disease control Stopped earlyThis phase 3 study tested an inhaled form of the antibiotic clofazimine added to standard therapy for people with MAC lung disease that did not respond to previous treatment. The goal was to see if the drug could clear the infection from sputum cultures and improve quality of lif…
Phase 3 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC